CVX
23
-2
UNP
50
4
ADT
55
25
WHR
57
2
MCD
46
4
FOX
30
2
NDAQ
48
3
PYPL
39
4
WFC
58
-3
NFLX
69
5
GILD
50
13
KMI
55
-4
DAL
48
-2
KR
50
10
TGNA
58
4
EXPE
66
2
MDLZ
36
4
ZTS
49
20
ROK
43
-4
PBI
30
7
CVX
23
-2
UNP
50
4
ADT
55
25
WHR
57
2
MCD
46
4
FOX
30
2
NDAQ
48
3
PYPL
39
4
WFC
58
-3
NFLX
69
5
GILD
50
13
KMI
55
-4
DAL
48
-2
KR
50
10
TGNA
58
4
EXPE
66
2
MDLZ
36
4
ZTS
49
20
ROK
43
-4
PBI
30
7
Financhill
Back

Redhill Biopharma Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
22

RDHL
Redhill Biopharma

Last Price:
0.37
Seasonality Move:
-1.06%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
22
Redhill Biopharma (RDHL) is a Sell

Is Redhill Biopharma a Buy, Sell or Hold?

  • The current Redhill Biopharma [RDHL] share price is $0.37. The Score for RDHL is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • RDHL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RDHL Stock Price Chart

What is Redhill Biopharma's stock price today?

  • The Redhill Biopharma share price today is $0.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RDHL is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

RDHL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 27.52 Sell
Chaikin Money Flow: -59781 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.4 - 0.48) Sell
Bollinger Bands (100): (0.43 - 0.55) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

RDHL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.39 Sell
20-day SMA: 0.43 Sell
50-day SMA: 0.44 Sell
200-day SMA: 0.67 Sell
8-day EMA: 0.39 Sell
20-day EMA: 0.42 Sell
50-day EMA: 0.46 Sell
200-day EMA: 2.01 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Redhill Biopharma Earnings Growth & RDHL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Redhill Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):